1. Context
2. Objectives
3. Methods
3.1. Study Design
3.2. Search Strategy
3.3. Study Selection
3.4. Quality Appraisal of Studies
4. Results
4.1. Study Selection
4.2. Quality Appraisal
4.3. Study Characteristics
| Writers and References | Type of Study | Demographic/Mortality Rate/Burning Percent | Types of Fungi | Specimens | Important Results/Signs and Symptoms; Prevention or Treatment Strategy |
|---|---|---|---|---|---|
| Wheeler et al. (11) | Case reports | NA | Fusarium spp., Fusarium oxysporum | Burn wounds | The incidence of fungal infections in burn patients has been growing because of the enhancement in antibacterial chemotherapy. Best strategy prevention: (1) Careful wound care: Usage of clean and sterile techniques in burn wound care and prevent fungal infections; (2) microbial surveillance: Perform regular microbiological tests, including colonic biopsies and histological and mycological examinations, for rapid and accurate identification of fungal infections. |
| Latenser (12) | Case report | A 40-year-old white male; 73% grease scald injury/patient died 55 days after injury | Fusarium spp., Candida spp. | Debridement, excision, and skin grafting | Deep-tissue involvement happens in immunocompromised patients with hematologic malignancies, aplastic anemia, and chemotherapy treatment. Monitoring high-risk patients: Cancer patients, those undergoing chemotherapy, and those with extensive burns should receive special care and close monitoring. |
| Hai et al. (13) | Case report | 53-year-old patient/the patient not recovered | F. equiseti | Histological examination (periodic acid-Schiff) and biopsy sampling | Antifungal susceptibility test is essential because multidrug resistance is usual among Fusarium strains/aggressive treatment/IV voriconazole. Management of the use of unconventional herbal medicines in burns, standard care and infection control measures, active surveillance, and increased attention to traditional medicines should be considered. |
| Tu et al. (14) | Case report | 44 burn patients/overall mortality rate 27.27% | Candidaalbicans, Fusarium spp., Zygomycetes | Surgical excision, debridement, skin graft, vitrectomy, teeth extraction, valve replacement, or amputation | The general mortality of fungal wound infection is high in burn patients around the world, markedly those infected with non-Candida spp. The three key factors or appropriate strategies are early diagnosis of fungal infection, early initiation of appropriate antifungal therapy, and effective surgical intervention to follow up on infection in burn patients. |
| Tram et al. (15) | Case report | 24-year-old male; extensive injuries 75% of body/the patient did not recover | F. solani;C.tropicalis | Histological examination of skin biopsy speimens; blood culture | F. solani was identified the most frequent pathogenic agent among Fusarium spp. 3 antifungal drugs caspofungin, fluconazole (for C. tropicalis), and voriconazole have been used for treatment, but were not effective against Fusarium. |
| Spesso et al. (16) | Retrospective study | 168 patients admitted to ICU, 29 burn patients; 13 male and 16 female; mortality rate of patients (24%) | Aspergillus spp.; Fusarium spp.; Mucor spp.; dematiaceous fungi | Skin biopsies and bedsores | Mortality among patients was 24% and Fusarium was involved in the highest number of deaths (50%). |
| Schaal et al. (17) | Retrospective study | 1849 patient/31 case have fungal infection/24 male and 7 female/6 cases of 22 people died | Aspergillus spp. (24 case); Fusarium spp. (3 case); Mucor spp. (9 case) | Biopsies or superficial swabs; wound biopsy; Sabouraud’s dextrose agar with and without chloramphenicol and blood agar | Filamentous fungal infections are basically cutaneous and rare and occur in the most severe burns. Voriconazole; amphotericin B; itraconazole; posaconazole; flucytosine; lipid formulations of amphotericin B three key prevention strategies include environmental controls (high air exchange rates, overpressurized operating rooms and operating theatres, etc.), use of infection control practices (strict aseptic techniques during dressings), and other additional measures such as proper maintenance and operation of preventive devices. |
| Rosanova et al. (21) | Retrospective, descriptive study | 15 patients/burn surface area (45%)/1 patient died | Fusarium spp. | Burn wound | Fusarium spp. was an unusual pathogen in severely pediatric burnt patients (amphotericin B, voriconazole). |
| Park et al. (22) | Case report | 82-year-old man with diabetes | Bisifusarium delphinoides, F.dimerum spp. complex | Deep swab specimen | Both diabetes mellitus and burns can be risk factors for Fusarium infection. |
| Palackic et al. (23) | Review | NA | C.albicans, Aspergillus and Zygomycetes, non- albicans Candida spp. | Debridement | The development of antifungal drugs is necessary due to the presence of drug-resistant fungi. Amphotericin B and voriconazole; Early radical debridement and wound closure are essential to prevent infection. Empirical prophylactic drug therapy should be considered for individuals at high risk of invasive burn wound infection. |
| Khalid et al. (24) | Case report | 8 patients from 3 - 57 y | F.dimerum | Debridement | Fusarium was responsible for 50% of deaths in burn patients (amphotericin B or voriconazoles). |
| Katz et al. (25) | Retrospective Study | Adult burns patients/two case died | Aspergillus fumigatus, Scedosporium prolificans, F. solani, Mucor spp., Absidia corymbifera, Penicillium spp., Alternaria spp. | Biopsy | Fungal or Candida infections have low mortality in the context of primary antifungal treatment; Important strategy early antifungal therapy extensive surgical debridement. Early closure of burn wounds, frequent microbiological evaluation of burn wounds, and aggressive surgical debridement of burn wounds are emphasized to prevent infection. |
| Goussous et al. (26) | Case report | 55-year-old male/35% TBSA | F. solani | Debridement tissue/elbow amputation | The risk factors of Fusarium are increased burns on total body surface, length of hospitalization, polymicrobial infections and the presence of inhalation injury; aggressive approach |
| Carrillo-Esper et al. (27) | Review | 26 cases | F. solani | NA | Immunosuppression and skin loss increase the frequency of fungal infections; voriconazole, posaconazole, and the lipid formulations of amphotericine B |
| Barrios et al. (28) | Case report | An adult burn patient/35% total body surface/improved | F. solani | NA | Focal neurologic deficits; Prolonged course of IV triple antifungal therapy |
| Piccoli et al. (29) | Review/24 case reports | 87 burn patients/1 to 85 y/male (53%) and female (47%)/78% burn surface/23 patients (37%) died | F.dimerum spp. complex | Histopathology | Amphotericin B voriconazole given the relatively high reported mortality rate of 37% of case reports, increasing understanding of the epidemiology of Fusarium and emphasizing clinical care among burn patients is critical for prevention. |
| Yen et al. (30) | Review | 81-year-old male/45 % of body surface | Fusarium spp. | Biopsy | Staphylococcus and Bacillus burn wound infections; Acinetobacterpneumonia; Cefazolin, ceftazidime, gentamycin |
| Barragan-Reyes et al. (31) | Retrospective series | 49 cases/22% of patients not recover. | Fusarium spp. | Biopsy/histopathology | Burn injuries (49%)/37% had hematological malignancies/monotherapy voriconazoleamphotericin B. |
| Jin et al. (32) | Case report | Average burnt 83.03% TBSA/13 male and 3 female/mortality rate (43.75%) | Candida spp., Fusarium spp., Aspergillus spp. | Bacteriological/organism | The most common fungi were Candida, Fusarium, Aspergillus, and fumigatus; In patients with burns caused by mass burn accidents, contact with water or soil should be considered as pathogenic and accelerating factors for infection for better prevention. |
| Akhavan et al. (33) | Retrospective review | 37 patients with atypical invasive fungal infections/five patient deaths (13.8%) | Aspergillus spp., Fusarium spp., Mucor spp. | NA | Aggressive treatment, first infectious disease consultation |
| Stevens et al. (34) | Case report | 40-year-old/died on hospital day 167 | Fusarium spp. | NA | Fungal brain abscess aspiration antifungal therapies |
| Delliere et al. (35) | Retrospective analysis | 15 patients | F. solani | Biopsy/histopathology | Pan-Fusarium qPCR assay in serum/plasma with high sensitivity, specificity, and reproducibility/circulating DNA for the diagnosis |
| Farooqi et al. (36) | Case report | 140 cases | Candida spp. Fusarium spp. | Bacterial cultures | Control and assess the frequency of fungal isolation in wound specimens |
| Louie et al. (37) | Case report | 1 case ill burn-injured patient | Fusarium spp. | Biopsy/scrapping | Topical liposomal amphotericin |
| Smolle et al. (38) | Case report | 17-year-old woman; 17% total body surface | Fusarium spp. | Wound swabs | Omega 3; Appropriate infection control and prevention strategies, in case of additional trauma complications, wound infection with resistant bacterial strains, complete debridement, wound preparation and subsequent dressing of burn wounds |
| Stempel et al. (39) | Retrospective analysis | 15 cases; average age 60 (26 - 78)/high mortality rate | F. solani | NA | Systemic glucocorticoids/voriconazole, terbinafine, amphotericin |
| Pruskowski et al. (40) | Analytical | NA | Aspergillus spp., Mucor spp. | NA | Histopathological evaluation/tissue culture surgical management systemic antifungals amphotericin B triazole antifungals |
| Jabeen et al. (41) | Retrospective study | 19 cases | Fusarium spp., Aspergillus flavus | Tissue cultures | Broad-spectrum antibiotics; Stated that it is crucial to review culture protocols in burn patients for prevention and optimal patient management. |
| Branski et al. (42) | Retrospective study | 398 patient/burns > 40% TBSA | Candida spp., Aspergillus spp., and Fusarium spp. | NA | Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter spp., and various fungal strains lead to increasing mortality rate. |
| Atty et al. (43) | Case report | Male, 92% TBSA | Fusarium and Mucor spp. | NA | Debridement and grafting |
| Farooqiet al. (36) | Retrospective study | 140 cases | Fusarium spp. | Bacterial cultures | Tissue cultures in local settings, accurate diagnosis and treatment are urgently needed. |
| Young et al. (44) | Retrospective study | 18 patients/average age (38.4 ± 11.9 y)/TBSA (54.5 ± 23.4 percent) mortality 45 percent | Fusarium spp. | NA | Clinical characteristics of Fusarium isolated cases |
| Stoianovici et al. (45) | Retrospective study | median age 35 (32 - 41); 28% female; TBSA (55 ± 23%) mortality 45 percent | Fusarium spp. | Tissue cultures | The cause of death was infection with multisystem organ failure and sepsis, which occurred in 88% of cases. The use of prolonged mechanical ventilation and central venous catheterization is essential. Given the high mortality rate associated with Fusarium infection and the long time to antifungal susceptibility results, an appropriate empiric treatment strategy is emphasized. |
| Gonzalez et al. (46) | Retrospective study | Male (69.8%), and the median age (5 y); 22 patients (35.48%) died | F. solani; F. oxysporum; Aspergillus spp., | Biopsies of burn patients | Suspicion of Fusarium infection is essential for the appropriate treatment strategy for burn patients, including prompt initiation of antifungal therapy and wound debridement. Other appropriate strategies to reduce patient mortality include the development of a comprehensive protocol for the evaluation of burn patients, implementation of an early surgical approach, use of early molecular methods and markers, and timely administration of antifungal therapy. |
Abbreviations: Spp., species; IV, intravenous; TBSA, total body surface area.
